Sage Journals: Discover world-class research

Retricted access

Review article

First published 2023-6

Vonoprazan: A New Potassium-Competitive Acid Blocker

Erin St. Onge, Bradley Phillips

Journal of Pharmacy Technology

Free access

Research article

First published 2012-2

High-Throughput Screening of Potassium-Competitive Acid Blockers

Mitsuyo Kondo, Makiko Kawamoto, Atsushi Hasuoka [...]

Journal of Biomolecular Screening

Open access

Research article

First published 2024-3

Potassium-Competitive Acid Blockers for the Treatment of Gastroesophageal Reflux Disease

Jiten P. Kothadia, Colin W. Howden

Foregut: The Journal of the American Foregut Society

Retricted access

Review article

First published 2025

Future Opportunities for Potassium Competitive Acid Blocker in Gastroesophageal Reflux Disease and Beyond

Noy Lapidot Alon, Richard Wong, Tomas Navarro-Rodriguez [...]

Foregut: The Journal of the American Foregut Society

Open access

Review article

First published 2018

Vonoprazan fumarate,a novel potassium-competitive acid blocker,in the management of gastroesophageal reflux disease: safety and clinical evidence to date

Kentaro Sugano

Therapeutic Advances in Gastroenterology

Open access

Review article

First published 2024

Potassium-competitive acid blockers and proton-pump inhibitors for healing of erosive esophagitis: a systematic review and network meta-analysis

Yin Liu, Zhifeng Gao, XiaoHua Hou

Therapeutic Advances in Gastroenterology

Open access

Review article

First published 2025-9

American Foregut Society White Paper Report on the Use of Potassium-Competitive Acid Blockers in the Treatment of Gastroesophageal Reflux Disease

Stuart Spechler, Jennifer M. Kolb, Kerry Dunbar [...]

Foregut: The Journal of the American Foregut Society

Open access

Review article

First published 2022

The role of vonoprazan in patients with erosive esophagitis

Mengyu Zhang, Yinglian Xiao, Minhu Chen

Therapeutic Advances in Gastroenterology

Retricted access

Brief report

First published 2022-2

Use of vonoprazan,a novel potassium-competitive acid blocker,for the treatment of proton pump inhibitor-refractory reflux esophagitis in patients with systemic sclerosis

Yuichiro Shirai, Noriyuki Kawami, Katsuhiko Iwakiri [...]

Journal of Scleroderma and Related Disorders

Free access

Review article

First published 2016-11

Vonoprazan-based therapy for Helicobacter pylori eradication: experience and clinical evidence

Yuko Akazawa, Daisuke Fukuda, Yutaka Fukuda

Therapeutic Advances in Gastroenterology

Search results